Robert Ang

Robert Ang is a highly accomplished professional with a diverse educational background and an impressive track record in the biopharmaceutical industry.

His educational journey includes studies at prestigious institutions such as Columbia University, Hollywood High School, The University of Western Australia, and Columbia Business School.

Robert currently holds the position of President and Chief Executive Officer at Vor Biopharma, where he leads the strategic direction and operations of the company.

His past experiences include serving on the boards of companies like Alliance for Regenerative Medicine and Enara Bio, as well as holding executive roles at Neon Therapeutics, Bavarian Nordic, and Cadence Pharmaceuticals.

Before stepping into leadership positions, Robert gained valuable experience in business development, medical affairs, and healthcare investment at renowned organizations like Frazier Healthcare Ventures, Boston Consulting Group (BCG), and Carrot Capital.

With a background in both medicine and business, Robert Ang brings a unique perspective to the biopharmaceutical sector, blending his expertise in medical affairs with his strategic acumen in entrepreneurship and finance.